Novavax Inc (NVAX)

[Golden Cross]

$100+ Coming!

[Golden Cross]

$60 will be the key break

[Golden Cross]

18% Short

[Golden Cross]

$NVAX Getting hot

[mick]

NVAX
Novavax Inc
58.00
10.46 (22.00%)
Volume: 1,946,165
Bid: 57.95
Ask: 58.05
Last Trade Time: 7:59:59 PM EDT
Total Trades: 21,598

[dinogreeves]

When you see the bigger picture, you will eventually get it.

[PStockPickz]

Market cap

Nvax 4.7 billion
JNJ 471 billion
PFE 300 Billion
MRNA 59 Billion


Question is, is it to late? We don't have a shortage anymore on vaccines.


Nvax insiders don't really own anything and they have income -1317.60M

[eastcoastguy]

good to see the advisory board recommend approval by the FDA. We've needed an alternative to Mrna. It's been quite a rollercoaster with NVAX. Lot of shorts, expect some shenanigans along the way. Would think the guidance of 4-5B in revenues for 2022 looks good. Low P/E and small float could lead to some fireworks. Wouldn't be surprised to see a buyout.

[dinogreeves]

Yes, Mick, I knew it would come, those tactics didn't work last week.

[mick]

$nvax IS APPROVED 1ST TIME SINCE COVID-19 [A.H. $59 PLUS]
3YRS IN DA MAKING.
VACCINE FER CHILDREN.
YOU KNOW IT IS GOOD [ 3-YRS IN DA MAKING.]
GIVEN TARGET $180
THAT SHOULD NOT BE HARD ALL-TIME HIGH
$480

[dinogreeves]

They just got approved, will likely trade after hours.

[ANTI-BAGHOLDER]

Damn. All day though? That’s crazy

[dinogreeves]

Yes, at the request of NVAX all day today, Chat.

[ANTI-BAGHOLDER]

Has this not been trading all day?

[dinogreeves]

We got the approval. Boom.

[diablose94]

Going with a recommend! Already have my calls purchased.

[dinogreeves]

6000 share total now, either I miss or hit, by Wednesday I should know.

[Atown62]

Did you see the subjects that developed the inflamed heart conditions were either already mrna vaxxed and the placebo to being statistical significant l definitely think it’s an overreaction and quite frankly manipulative in some ways.

I expect approval they have to with other countries including Canada are authorized to use

[vinmantoo]

I thought the overall report was good. Bought the dip and we'll see how that turns out.

The efficacy data was good. However, the side effect data was troubling, especially the myocarditis data which was worse than reported for the mRNA vaccines. I do think NVAX could get FDA approval so kept 1/3 of my shares. I am hoping FDA approval comes. My longer term concern is that NVAX had been touting its vaccine as being safer than mRNA vaccines but they may not be able to do that anymore. They will still be selling vaccine world wide and sales will go up if the FDA approves. My concern is that the other nearer term price driver is the NVAX combination flu/Covid vaccine and that could be affected too.

Good luck to both of us!

[eastcoastguy]

I thought the overall report was good. Bought the dip and we'll see how that turns out.

[dinogreeves]

I added again on that ridiculous dip yesterday. This will recover next week.

[Tamtam]

B.Riley Financial Thinks Novavax’s Stock is Going to Recover
https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/stock-news/88283845/b-riley-financial-thinks-novavax-s-stock-is-going

[Atown62]

Placebo had basically the same lol

[vinmantoo]

Here is a link to the FDA document, which was provided by Mouton29 on the Biotech Values board.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169046552

It is depressing. The efficacy was good. The side-effects after the first dose wasn't an issue fine but what is troubling is the jump in grade 3 side effects after the second dose. I sold off 2/3 of my position based on that.

It may be that the FDA wasn't as aware or concerned about side-effect after the low incidence of myocarditis in mRNA vaccines than when they were approved. I looked up the incidence of myocarditis in mRNA vaccines but it is ~1 per 100,000, which is an order of magnitude lower than this reports says for NVAX.

[dinogreeves]

128 million dollar buy at the bell, whether that was short covering or not. We will find out this week and next week.

[chrismiss_everyday]

https://www.medrxiv.org/content/10.1101/2022.05.27.22275375v1?ct=

[vinmantoo]

Couldn't believe the opportunity after the 1st Q earnings report. NVAX makes a profit for the first time, confirms guidance, and gets hammered. Great opportunity to add shares.

We are in the same boat.

I'm confident we'll get US approval and gain market share on the MRNA vaccine.

I very hopeful about FDA approval but I never count my chickens before they hatch.

[eastcoastguy]

I watched this for 6 months and jumped in as I closed out a short Naz position. Couldn't believe the opportunity after the 1st Q earnings report. NVAX makes a profit for the first time, confirms guidance, and gets hammered. Great opportunity to add shares. I'm confident we'll get US approval and gain market share on the MRNA vaccine.

go Celts,
eastcoastguy

[dinogreeves]

$20.00 EPS coming here after approval by end of next year.

[dinogreeves]

I am sitting on 4000 shares. Just fasten your seatbelts and watch.

[vinmantoo]

All time high by end of June.

I am an NVAX shareholder and I doubled my shares when it fell into the mid $40s last week. FDA approval will give NVAX stock price a nice boost but no way is the stock price going to come close to its all-time high.

[dinogreeves]

All eyes on NVAX. All time high by end of June.

[Tamtam]

NVAX up 19%, that is a long time ago

[mick]

Can Novavax Rebuild Investor Confidence? Analyst Weighs In • TipRanks • 04/30/2022 12:51:27 AM
Novavax Shares Jump as FDA Plans Vaccine Review • Dow Jones News • 04/29/2022 03:17:00 PM

[mick]

Novavax Inc (NVAX)
45.3 ? 1.03 (2.33%)
Volume: 7,743,242 @04/29/22 7:59:55 PM EDT
Bid Ask Day's Range
45.3 45.45 44.9 - 52.4796
NVAX Detailed Quote

[Zilla]

Down to low 46... FDA delay and overall market may take it even lower...Was 4 bucks I think before covid so...YIKES!!!

[bleu22]

https://www.nippon.com/en/news/yjj2022041800506/

[Meowza]

When is Merck's production line for JnJ's dead end AVV vaccine going to come online?

Still cant figure out why gov't wanted to a retool protein-based manufacturing for AVV, instead of Novavax.

[Tamtam]

New Covid Variant XE Found In UK, More Transmissible Than Omicron: WHO
https://www.ndtv.com/world-news/new-covid-variant-xe-found-in-uk-more-transmissible-than-omicron-who-2858643

[vinmantoo]

NVAX sure is a roller coaster ride. One day it will become a rocket ship, hopefully sooner rather than later.

[mick]

Novavax Inc (NVAX)
73.49 ? -4.28 (-5.50%)
Volume: 2,953,331 @03/11/22 7:59:30 PM EST
Bid Ask Day's Range
73.02 73.5 72.56 - 80.481
NVAX Detailed Quote

[Tamtam]

Agree

[gastric]

NVAX needs to produce and deliver product. Approvals are no longer the issue.

[double_m]

Canada approves Novavaxs COVID-19 vaccine
10:27 AM ET 2/17/22 | Reuters
Canada approves Novavax's COVID-19 vaccine
Feb 17 (Reuters) - Canada's health regular said on Thursday it approved Novavax's COVID-19 vaccine for use in people aged 18 years and older.

The vaccine's safety and effectiveness in people younger than 18 years of age have not yet been established, Health Canada said in its release. (Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)

[chrismiss_everyday]

Novavax Statement on First Administration of its COVID-19 Vaccine in Australia

The first dose of Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) was administered today in Australia during a press briefing by The Hon Greg Hunt MP, Federal Minister for Health and Aged Care. Nuvaxovid is the first protein-based COVID-19 vaccine to receive approval for provisional registration by the Therapeutic Goods Administration (TGA).

The TGA granted approval for provisional registration of Nuvaxovid for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 18 years of age and older on January 19.

Novavax is proud to start delivering its vaccine to the people of Australia during a critical time as the pandemic shows no signs of retreat. Australia has played a pivotal role in Novavax' Phase 1 and Phase 2 clinical trials supporting the development of Nuvaxovid. Additionally, a booster trial for Nuvaxovid and a Phase 1/2 trial for a combination seasonal influenza and COVID-19 vaccine are currently underway in Australia.

Novavax and the Commonwealth of Australia have an advance purchase agreement for 51 million doses of Nuvaxovid, with the option for an additional 10 million doses (up to 61 million doses total). Plans are actively underway to begin the delivery process for Nuvaxovid doses across Australia.

[gastric]

2B doses were ordered. To start with. They simply need to be able to deliver.

[Tamtam]

I hope so

[chrismiss_everyday]

https://www.nasdaq.com/market-activity/stocks/nvax/earnings

Going to be a fantastic year.

[Tamtam]

Novavax’s newest approvals position it as an mRNA ‘alternative’ that health officials say may convince vaccine skeptics
https://fortune.com/2022/02/04/novavax-vaccine-us-approval-uk-new-zealand-mrna-protein-alternative/amp/

[mick]

Novavax Inc (NVAX)
89.65 ? 1.16 (1.31%)
Volume: 3,314,610 @02/04/22 7:59:50 PM EST
Bid Ask Day's Range
84.24 94.14 87.5 - 91.65
NVAX Detailed Quote